SVA
Sinovac Biotech Ltd
NASDAQ: SVA · HEALTHCARE · BIOTECHNOLOGY
$6.47
+0.00% today
Updated 2026-04-29
Market cap
$642.44M
P/E ratio
6.66
P/S ratio
1.83x
EPS (TTM)
$0.97
Dividend yield
850.00%
52W range
$6 – $6
Volume
—
Sinovac Biotech Ltd (SVA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.54M | $-1.13M | $-1.64M | $4.32M | $10.50M | $48.41M | $-14.28M | $13.94M | $-16.25M | $5.58M | $-10.13M | $4.21M | $-15.46M | $59.76M | $7.94M | $39.07M | $479.31M | $15.35B | $-770.75M | $106.02M |
| Capital expenditures | $1.65M | $1.65M | $1.14M | $2.47M | $3.98M | $4.32M | $25.38M | $15.46M | $16.16M | $5.13M | $10.91M | $5.30M | $12.65M | $11.91M | $5.61M | $10.63M | $127.65M | $719.98M | $403.37M | $145.69M |
| Depreciation | $899185.00 | $899185.00 | $1.27M | $1.40M | $1.77M | $2.24M | $4.23M | $4.83M | $4.49M | $6.41M | $8.10M | $6.52M | $5.31M | $4.88M | $5.14M | $4.82M | $4.04M | $86.83M | $156.60M | $144.75M |
| Stock-based comp | $439904.00 | — | $-132314.00 | $2.72M | $66542.00 | $422860.00 | $459901.00 | $206000.00 | $347000.00 | $281000.00 | $287000.00 | $952000.00 | $2.41M | $979000.00 | $4.30M | $3.00M | $10.20M | $7.74M | $149.49M | $0.00 |
| Free cash flow | $-3.19M | $-2.78M | $-2.78M | $1.85M | $6.53M | $44.09M | $-39.66M | $-1.52M | $-32.41M | $443000.00 | $-21.04M | $-1.09M | $-28.11M | $47.84M | $2.33M | $28.45M | $351.66M | $14.63B | $-1.17B | $-39.67M |
| Investing cash flow | $-3.05M | — | $-569318.00 | $-2.44M | $-3.96M | $-11.69M | $-19.24M | $-13.79M | $-16.15M | $-5.18M | $-11.00M | $-4.51M | $-11.78M | $-11.90M | $-25.26M | $-42.45M | $-204.76M | $-3.02B | $-5.76B | $-2.93B |
| Financing cash flow | $5.78M | $6.55M | $3.98M | $5.56M | $8.32M | $5.29M | $58.19M | $613000.00 | $17.33M | $14.42M | $5.31M | $-24.20M | $27.78M | $-1.34M | $64.18M | $1.74M | $592.57M | $-1.90B | $-241.40M | $-76.06M |
| Dividends paid | — | $379123.00 | $379123.00 | — | $2.95M | $3.85M | $3.29M | — | — | $649000.00 | $649000.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $0.00 | $1.88B | $263.17M | $328.08M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |